Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Ozanimod in Relapsing Multiple Sclerosis: New Insights
7
Mins
December 2024
Ozanimod is a sphingosine 1-phosphate (S1P) receptor 1 and 5 (S1PR1 and S1PR5) modulator approved in multiple countries for the…
Read more
7
Mins
4 Dec 2024
Ozanimod in Relapsing Multiple Sclerosis: New Insights
Ozanimod is a sphingosine 1-phosphate (S1P) receptor 1 and 5 (S1PR1 and S1PR5) modulator approved in multiple countries for the…
10
Mins
30 May 2024
Interview: Yaakov Stern
When I was doing my BA in psychology, I found myself more interested in the research side of the subject; a lot of people who were…
9
Mins
30 May 2024
Updated Study Data for Ozanimod in Relapsing Multiple Sclerosis
Presenting data from ENLIGHTEN and DAYBREAK, covering cognitive processing, brain volume, disability progression, rebound, and…
12
Mins
17 May 2024
Interview: Jacqueline A. French
I feel like epilepsy is the ‘window’ into the brain, because when people have a seizure, their onset tells you a lot about that area of…
4
Mins
16 May 2024
Movement Disorder: Initial Manifestation of Hereditary Hemochromatosis – A Case Report
Hemochromatosis is a genetic disorder characterized by pathological tissue iron deposition with multiple organ involvement…
6
Mins
13 May 2024
Pediatric Tics After Mild Traumatic Brain Injury: A Sui Generis Case Series
Traumatic brain injury (TBI) is a significant public health concern in Canada, with falls, blows to the head, car accidents…
6
Mins
7 May 2024
Neurological Presentation of Lead Toxicity
Acute encephalopathy is a significant cause of morbidity and mortality in young children. It can be caused by infectious agents, metabolic…
9
Mins
19 Apr 2024
Optical Coherence Tomography Angiography in Multiple Sclerosis
This study aims to evaluate changes in retinal microvasculature in patients with multiple sclerosis (MS) by means of optic coherence…
Loading posts...
1
2
Next »